Mount Sinai Health System · 10 hours ago
Postdoctoral Fellow-MSH-32076-156
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, and they are seeking a highly motivated postdoc to lead projects aimed at developing myeloid cell targeted therapies for cancer treatment. The role involves performing independent research in cancer therapy, analyzing data, and collaborating with other scientists.
Health CareHospitalMedical
Responsibilities
To advance the application of macrophage-targeted CAR T cells
To develop improved ways to arm CAR T cells to remodel the tumor microenvironment
To develop technologies to spatially localize remodeling factors in the tumor microenvironment
Perform independent research in the area of cancer therapy, this will include molecular cloning, vector production, cell isolation, and testing in vivo in preclinical models of different cancers
Critically analyze data quality and results, communicate results to scientists and lay people
Write or assist in writing scientific papers and grants
Collaborate closely with other scientists to conduct research
Qualification
Required
Ph.D. required
Experience working in a research laboratory setting
Company
Mount Sinai Health System
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
H1B Sponsorship
Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageTotal Funding
$41.9MKey Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
Leadership Team
Recent News
Digital Journal
2026-01-08
Company data provided by crunchbase